Amgen Cleared Again On Kanjinti As Trial Looms

Denial Of Preliminary Injunction Upheld On Appeal

 
• By Dean Rudge
Gavel
Amgen launched biosimilar trastuzumab in the US last July • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin